Search Results

Filter
  • 1-10 of  31,239 results for ""Buprenorphine""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Buprenorphine microdosing regimen using transdermal buprenorphine patches to transition from methadone to buprenorphine.

  • Authors : Naren T; Drug Health Services, Western Health, Melbourne, Australia.; cohealth Innerspace, Melbourne, Australia.

Subjects: Buprenorphine*/Buprenorphine*/Buprenorphine*/administration & dosage ; Methadone*/Methadone*/Methadone*/administration & dosage ; Opiate Substitution Treatment*/Opiate Substitution Treatment*/Opiate Substitution Treatment*/methods

  • Source: Drug and alcohol review [Drug Alcohol Rev] 2024 May; Vol. 43 (4), pp. 1013-1018. Date of Electronic Publication: 2024 Feb 26.Publisher: Wiley-Blackwell Country of Publication: Australia NLM ID: 9015440 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Did the 2021 federal change in the practice guidelines for the administration of buprenorphine for treating opioid use disorder increase buprenorphine prescription dispensing in Medicaid population?

  • Authors : Qian J; Department of Health Outcomes Research and Policy, Auburn University Harrison College of Pharmacy, Auburn, Alabama, USA.; Khatiwada AP

Subjects: Buprenorphine*/Buprenorphine*/Buprenorphine*/therapeutic use ; Opioid-Related Disorders*/Opioid-Related Disorders*/Opioid-Related Disorders*/drug therapy; United States

  • Source: The American journal on addictions [Am J Addict] 2024 May; Vol. 33 (3), pp. 335-338. Date of Electronic Publication: 2023 Dec 09.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9208821 Publication Model: Print-Electronic Cited Medium:

Record details

×
Report

Extended-release buprenorphine in pregnancy.

  • Authors : Hubbell A; M Health Fairview Addiction Medicine, University of Minnesota, Minneapolis, Minnesota, USA.; Aghenta E

Subjects: Buprenorphine*/Buprenorphine*/Buprenorphine*/adverse effects ; Opioid-Related Disorders*/Opioid-Related Disorders*/Opioid-Related Disorders*/drug therapy ; Opioid-Related Disorders*/Opioid-Related Disorders*/Opioid-Related Disorders*/epidemiology

  • Source: The American journal on addictions [Am J Addict] 2024 May; Vol. 33 (3), pp. 354-356. Date of Electronic Publication: 2024 Jan 24.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9208821 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Open-label investigation of rapid initiation of extended-release buprenorphine in patients using fentanyl and fentanyl analogs.

  • Authors : Mariani JJ; Division on Substance Use Disorders, New York State Psychiatric Institute, New York, New York, USA.; Department of Psychiatry, Columbia University Irving Medical Center, New York, New York, USA.

Subjects: Buprenorphine* ; Opioid-Related Disorders*/Opioid-Related Disorders*/Opioid-Related Disorders*/drug therapy; Humans

  • Source: The American journal on addictions [Am J Addict] 2024 Jan; Vol. 33 (1), pp. 8-14. Date of Electronic Publication: 2023 Nov 08.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9208821 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

Commentary on the current state of perioperative and critical care buprenorphine management.

  • Authors : Quaye A; Department of Anesthesiology and Perioperative Medicine, Maine Medical Center, Portland, Maine, USA.; Spectrum Healthcare Partners, South Portland, Maine, USA.

Subjects: Buprenorphine*/Buprenorphine*/Buprenorphine*/therapeutic use ; Opioid-Related Disorders*/Opioid-Related Disorders*/Opioid-Related Disorders*/drug therapy; Humans

  • Source: Addiction (Abingdon, England) [Addiction] 2024 Jan; Vol. 119 (1), pp. 200-201. Date of Electronic Publication: 2023 Sep 28.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9304118 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

The association between longitudinal trends in receipt of buprenorphine for opioid use disorder and buprenorphine-waivered providers in the United States.

  • Authors : Stringfellow EJ; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Lim TY

Subjects: Buprenorphine*/Buprenorphine*/Buprenorphine*/therapeutic use ; Opioid-Related Disorders*/Opioid-Related Disorders*/Opioid-Related Disorders*/drug therapy; Humans

  • Source: Addiction (Abingdon, England) [Addiction] 2023 Nov; Vol. 118 (11), pp. 2215-2219. Date of Electronic Publication: 2023 Jul 11.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9304118 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Postoperative buprenorphine continuation in stabilized buprenorphine patients: A population cohort study.

  • Authors : Hauck TS; Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; Institute of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.

Subjects: Buprenorphine*/Buprenorphine*/Buprenorphine*/therapeutic use ; Opioid-Related Disorders*/Opioid-Related Disorders*/Opioid-Related Disorders*/drug therapy; Adult

  • Source: Addiction (Abingdon, England) [Addiction] 2023 Oct; Vol. 118 (10), pp. 1953-1964. Date of Electronic Publication: 2023 Jun 18.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9304118 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Associations of methadone and buprenorphine-naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription-type opioid use disorders: Exploratory analyses of the OPTIMA study.

Subjects: Opioid-Related Disorders*/Opioid-Related Disorders*/Opioid-Related Disorders*/drug therapy ; Buprenorphine*/Buprenorphine*/Buprenorphine*/adverse effects; Humans

  • Source: The American journal on addictions [Am J Addict] 2023 Sep; Vol. 32 (5), pp. 469-478. Date of Electronic Publication: 2023 Jun 12.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9208821 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Patients' experiences with continuation or discontinuation of buprenorphine before painful procedures: A brief report.

  • Authors : Hathaway DB; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.

Subjects: Buprenorphine*/Buprenorphine*/Buprenorphine*/therapeutic use ; Opioid-Related Disorders*/Opioid-Related Disorders*/Opioid-Related Disorders*/drug therapy; Humans

  • Source: The American journal on addictions [Am J Addict] 2023 Jul; Vol. 32 (4), pp. 410-414. Date of Electronic Publication: 2023 Feb 27.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9208821 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Are DEA-waivered buprenorphine prescribers colocated with behavioral health clinicians?

  • Authors : Zerden LS; School of Social Work, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Cecil G. Sheps Center for Health Services Research, UNC Behavioral Health Workforce Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Subjects: Buprenorphine*/Buprenorphine*/Buprenorphine*/therapeutic use ; Opioid-Related Disorders*/Opioid-Related Disorders*/Opioid-Related Disorders*/drug therapy ; Physicians*

  • Source: The American journal on addictions [Am J Addict] 2023 Nov; Vol. 32 (6), pp. 574-583. Date of Electronic Publication: 2023 Aug 09.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9208821 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  31,239 results for ""Buprenorphine""